Anaemia affects around half a billion women aged 15 to 49 worldwide, and the WHO African and South-East Asia regions together account for more than 60% of that burden. In South Asia the current figure is 259 million, with 18 million more projected by 2030.
47 of these 164 lines are injectable and 12 are large-volume IV infusions, the range hospital wards and institutional supply run on.
Range depth
4 iron sucrose presentations.
Full B-complex parenteral range.
12 large-volume parenteral lines.
18 calcium presentations and OTC analgesic combinations.
We establish what is already registered in your market, who supplies it today, and where demand is going unmet.
We set your current range against the portfolio and separate genuine gaps from lines you already stock.
You get the molecules in filing order, which of them need a dossier built for your authority, and which fall outside the range.
We compile the dossier in CTD format for your authority and supply the COPP and plant-level WHO-GMP and PIC/S certificates behind it.
We analyse your market and set your existing range against the portfolio, then return the molecules worth filing in priority order with the documentation route for each.